398 related articles for article (PubMed ID: 7807190)
1. A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.
Stewart DJ
J Neurooncol; 1994; 20(2):121-39. PubMed ID: 7807190
[TBL] [Abstract][Full Text] [Related]
2. Do anticancer agents reach the tumor target in the human brain?
Donelli MG; Zucchetti M; D'Incalci M
Cancer Chemother Pharmacol; 1992; 30(4):251-60. PubMed ID: 1643692
[TBL] [Abstract][Full Text] [Related]
3. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin and radiation in the treatment of tumors of the central nervous system: pharmacological considerations and results of early studies.
Stewart DJ; Molepo JM; Eapen L; Montpetit VA; Goel R; Wong PT; Popovic P; Taylor KD; Raaphorst GP
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):531-42. PubMed ID: 8276672
[TBL] [Abstract][Full Text] [Related]
5. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacologic bases of chemotherapy of brain tumors in children].
Vassal G
Bull Cancer; 1990; 77(7):699-713. PubMed ID: 2207360
[TBL] [Abstract][Full Text] [Related]
8. Quantification and pharmacokinetics of blood-brain barrier disruption in humans.
Zünkeler B; Carson RE; Olson J; Blasberg RG; DeVroom H; Lutz RJ; Saris SC; Wright DC; Kammerer W; Patronas NJ; Dedrick RL; Herscovitch P; Oldfield EH
J Neurosurg; 1996 Dec; 85(6):1056-65. PubMed ID: 8929495
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier and chemotherapeutic treatment of brain tumors.
de Vries NA; Beijnen JH; Boogerd W; van Tellingen O
Expert Rev Neurother; 2006 Aug; 6(8):1199-209. PubMed ID: 16893347
[TBL] [Abstract][Full Text] [Related]
11. Model for drug uptake by brain tumors: effects of osmotic treatment and of diffusion in brain.
Robinson PJ; Rapoport SI
J Cereb Blood Flow Metab; 1990 Mar; 10(2):153-61. PubMed ID: 2303532
[TBL] [Abstract][Full Text] [Related]
12. Obstacles to Brain Tumor Therapy: Key ABC Transporters.
Wijaya J; Fukuda Y; Schuetz JD
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186899
[TBL] [Abstract][Full Text] [Related]
13. [The blood-brain barrier: implications for chemotherapy in brain tumors].
Boaziz C; Breau JL; Morère JF; Israël L
Pathol Biol (Paris); 1991 Oct; 39(8):789-95. PubMed ID: 1762838
[TBL] [Abstract][Full Text] [Related]
14. Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.
Wang Z; Sun H; Yakisich JS
Anticancer Agents Med Chem; 2014; 14(8):1085-93. PubMed ID: 23092271
[TBL] [Abstract][Full Text] [Related]
15. Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting.
Doolittle ND; Peereboom DM; Christoforidis GA; Hall WA; Palmieri D; Brock PR; Campbell KC; Dickey DT; Muldoon LL; O'Neill BP; Peterson DR; Pollock B; Soussain C; Smith Q; Tyson RM; Neuwelt EA
J Neurooncol; 2007 Jan; 81(1):81-91. PubMed ID: 16858513
[TBL] [Abstract][Full Text] [Related]
16. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
[TBL] [Abstract][Full Text] [Related]
17. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
[TBL] [Abstract][Full Text] [Related]
18. Human central nervous system pharmacology of pentamethylmelamine and its metabolites.
Stewart DJ; Benvenuto JA; Leavens M; Smith RG; Cabanillas F; Benjamin RS; Loo TL
J Neurooncol; 1983; 1(4):357-64. PubMed ID: 6432969
[TBL] [Abstract][Full Text] [Related]
19. [The effect on the tumor vessel permeability by hyperosmotic blood brain barrier disruption].
Miyagami M; Tazoe M; Kagawa Y; Tsubokawa T
No To Shinkei; 1988 Sep; 40(9):875-82. PubMed ID: 3142506
[TBL] [Abstract][Full Text] [Related]
20. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.
Timbie KF; Afzal U; Date A; Zhang C; Song J; Wilson Miller G; Suk JS; Hanes J; Price RJ
J Control Release; 2017 Oct; 263():120-131. PubMed ID: 28288892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]